Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Income from Continuing Operations (2018 - 2025)

Dna X's Income from Continuing Operations history spans 8 years, with the latest figure at 3454000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 3454000.0 for Q4 2025, down 61.26% from a year ago — trailing twelve months through Dec 2025 was 8316000.0 (down 166.62% YoY), and the annual figure for FY2025 was 7955000.0, down 155.05%.
  • Income from Continuing Operations for Q4 2025 was 3454000.0 at Dna X, up from 4753000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 8915000.0 in Q4 2024 to a low of 11722000.0 in Q4 2021.
  • The 5-year median for Income from Continuing Operations is 2709000.0 (2024), against an average of 3187400.0.
  • Peak annual rise in Income from Continuing Operations hit 1134.22% in 2024, while the deepest fall reached 1399.8% in 2024.
  • Year by year, Income from Continuing Operations stood at 11722000.0 in 2021, then soared by 91.11% to 1042000.0 in 2022, then increased by 17.27% to 862000.0 in 2023, then surged by 1134.22% to 8915000.0 in 2024, then plummeted by 61.26% to 3454000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 3454000.0, 4753000.0, and 7475000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.